CCR2 Chemokine Receptor and AIDS Progression

Authors

• Michael W. Smith, National Cancer Institute at Frederick
• Mary Carrington, National Cancer Institute at Frederick
• Cheryl Winkler, National Cancer Institute at Frederick
• Deborah A. Lomb, National Cancer Institute at Frederick
• Michael Dean, National Cancer Institute at Frederick
• Gavin A. Huttley, National Cancer Institute at Frederick
• Stephen J. O'Brien, National Cancer Institute at FrederickFollow

ORCID

0000-0001-7353-8301

ResearcherID

N-1726-2015

Document Type

Article

Publication Title

Nature Medicine

ISSN

1078-8956

Publication Date

10-1997

Abstract

Recently we reported an association between the CCR2-64I chemokine receptor mutation and delayed onset of AIDS. Michael et al. have now examined the San Francisco Mens Health Study (SFMHS) AIDS cohort for CCR2 genotypes and in this issue of Nature Medicine report that they fail to detect the CCR2-64I association.

Volume

3

Issue

10

First Page

1052

Last Page

1053

Comments

©1997 Nature Publishing Group

NSUWorks Citation

Smith, Michael W.; Mary Carrington; Cheryl Winkler; Deborah A. Lomb; Michael Dean; Gavin A. Huttley; and Stephen J. O'Brien. 1997. "CCR2 Chemokine Receptor and AIDS Progression." Nature Medicine 3, (10): 1052-1053. https://nsuworks.nova.edu/cnso_bio_facarticles/673